Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal. [electronic resource]
Producer: 20100107Description: 4171-9 p. digitalISSN:- 1945-7197
- Adenocarcinoma, Follicular -- drug therapy
- Adult
- Aged
- Carcinoma, Papillary -- drug therapy
- Combined Modality Therapy
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Iodine Radioisotopes -- therapeutic use
- Male
- Middle Aged
- Recombinant Proteins -- therapeutic use
- Thyroglobulin -- blood
- Thyroid Hormones -- administration & dosage
- Thyroid Neoplasms -- drug therapy
- Thyroidectomy
- Thyrotropin -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.